Evolving experience of HBV prophylaxis in liver transplant recipients.

被引：0
|
作者：
Honaker, MR
Shokkouh-Amiri, MH
Alloway, RR
Grewal, HP
Hardinger, KL
Kizilisik, TA
Bagous, T
Trofe, J
Vera, SR
Stratta, RJ
Egidi, MF
Gaber, AO
机构：
[1] Univ Tennessee, Coll Pharm, Memphis, TN USA
[2] Univ Tennessee, Coll Med, Memphis, TN USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
779
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [1] Evolving Trends in Demographic and Medical Characteristics of Liver Transplant Recipients.
    Rosenblatt, R.
    Shen, N.
    Tafesh, Z.
    Fortune, B.
    Halazun, K.
    Jesudian, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 273 - 273
  • [2] Impact of Fluconazole Prophylaxis on Fungal Infections in Liver Transplant Recipients.
    Roach, K.
    Todd, S.
    Lyon, M.
    Subramanian, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 886 - 886
  • [3] HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence
    Karasu, Z
    Ozacar, T
    Akarca, U
    Ersoz, G
    Erensoy, S
    Gunsar, F
    Kobat, A
    Tokat, Y
    Batur, Y
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) : 212 - 215
  • [4] Malaria prophylaxis and immunosuppression: The travel experience of three paediatric transplant recipients.
    Nalli, N
    Martin, K
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 116 - 116
  • [5] Incidence of CMV with dual therapy prophylaxis in orthotopic liver transplant recipients.
    Ashcraft, EE
    Baillie, GM
    Polito, CC
    Buchanan, EP
    Rodwell, D
    Brown, E
    Rogers, J
    Lin, A
    Baliga, PK
    Chavin, KD
    HEPATOLOGY, 2002, 36 (04) : 661A - 661A
  • [6] Comparison of CMV prophylaxis and preemptive therapy in liver and kidney transplant recipients.
    Taber, DJ
    Dupuis, RE
    Hollar, KD
    Meehan, A
    Rodegast, B
    Salm, J
    Zacks, S
    Shrestha, R
    Gerber, D
    Johnson, MW
    TRANSPLANTATION, 2000, 69 (08) : S181 - S181
  • [7] An RCT of ganciclovir prophylaxis for CMV disease in pediatric liver transplant recipients.
    King, SM
    Superina, R
    Andrews, W
    Winston, D
    Dunn, S
    Colombani, P
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 243 - 243
  • [8] Evaluation of the impact of an oral cytomegalovirus prophylaxis regimen in liver transplant recipients.
    Quan, DJ
    Hirata, J
    PHARMACOTHERAPY, 2003, 23 (10): : 1365 - 1365
  • [9] LIVER SURGERY IN LIVER TRANSPLANT RECIPIENTS.
    Sommacale, Daniele
    Nagarajan, Ganesh
    Dondero, Federica
    Dokmak, Safi
    Sauvanet, Alain
    Francoz, Claire
    Durand, Francois
    Belghiti, Jacques
    LIVER TRANSPLANTATION, 2009, 15 (07) : S164 - S164
  • [10] Hyperhomocysteinemia in liver transplant recipients.
    Ali, A
    Befeler, AS
    Bacon, BR
    Varma, C
    Solomon, W
    Ramrakhiani, S
    TRANSPLANTATION, 2000, 69 (08) : S391 - S391
12345